Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Avanos Medical Inc (AVNS)

Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference PR Newswire - Mon Mar 2, 4:28PM CST

ALPHARETTA, Ga. , March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief...

AVNS : 13.12 (-1.28%)
Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors PR Newswire - Thu Feb 26, 6:00AM CST

Enters into Agreement with Bradley L. Radoff

AVNS : 13.12 (-1.28%)
Avanos Medical: Q4 Earnings Snapshot AP - Tue Feb 24, 6:27AM CST

Avanos Medical: Q4 Earnings Snapshot

AVNS : 13.12 (-1.28%)
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results PR Newswire - Tue Feb 24, 6:00AM CST

ALPHARETTA, Ga. , Feb. 24, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2025 results.

AVNS : 13.12 (-1.28%)
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results PR Newswire - Mon Feb 16, 3:30PM CST

ALPHARETTA, Ga. , Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and...

AVNS : 13.12 (-1.28%)
CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026 PR Newswire - Tue Feb 3, 7:00AM CST

ALPHARETTA, Ga. , Feb. 3, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Hospital...

AVNS : 13.12 (-1.28%)
Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management PR Newswire - Tue Jan 20, 7:00AM CST

ALPHARETTA, Ga. , Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthineers today announced a strategic co-marketing agreement to advance outpatient and interventional...

AVNS : 13.12 (-1.28%)
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors Business Wire - Fri Jan 9, 6:00AM CST

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced...

HYPR : 1.1600 (+8.41%)
OFIX : 12.46 (-1.27%)
SPNC : 38.45 (unch)
AVNS : 13.12 (-1.28%)
PLSE : 18.25 (+0.63%)
SWAV : 334.75 (-0.02%)
Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire - Wed Jan 7, 7:25PM CST

ALPHARETTA, Ga. , Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44 th Annual J.P. Morgan Healthcare...

AVNS : 13.12 (-1.28%)
Avanos Medical: Q3 Earnings Snapshot AP - Wed Nov 5, 2025

Avanos Medical: Q3 Earnings Snapshot

AVNS : 13.12 (-1.28%)

Barchart Exclusives

2 High-Yield Dividend Stocks to Buy Now Amid the U.S.-Iran War Barchart - Mon Mar 9, 6:30PM CDT
J.P. Morgan’s more bullish stance on select European majors makes sense here, because Eni and TotalEnergies combine mid‑single‑digit yields, below‑sector valuation multiples, and diversified upstream, downstream, and renewables portfolios that can monetize a sustained Middle East risk premium while still paying investors to wait. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot